Carisbamate has powerful disease-modifying effects in the lithium-pilocarpine model of temporal lobe epilepsy

Neuropharmacology

Volumn 61, Issue 1-2, 2011, Pages 313-328

  François, Jennifer ^a   Germe, Katuschia ^a   Ferrandon, Arielle ^a   Koning, Estelle ^a   Nehlig, Astrid ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Carisbamate; Epileptogenesis; Lithium pilocarpine model; Neuroprotection; Temporal lobe epilepsy

Indexed keywords

CARISBAMATE; DIAZEPAM; LITHIUM DERIVATIVE; PILOCARPINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN REGION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; ELECTROENCEPHALOGRAPHY; HIPPOCAMPAL MOSSY FIBER; HIPPOCAMPUS; MALE; NERVE SPROUTING; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SEIZURE; SPIKE; SPIKE WAVE; TEMPORAL LOBE EPILEPSY; THALAMUS; TREATMENT DURATION;

ANIMALS; CARBAMATES; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; LITHIUM CHLORIDE; MALE; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79957791720     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.04.018     Document Type: Article

References (57)

1. Andre, V., Ferrandon, A., Marescaux, C., Nehlig, A., 2001. Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res. 47, 99-117. (Pubitemid 32973652)
2. Andre, V., Rigoulot, M.A., Koning, E., Ferrandon, A., Nehlig, A., 2003. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat. Epilepsia 44, 893-903. (Pubitemid 36842178)
3. André, V., Ferrandon, A., Marescaux, C., Nehlig, A., 2000. Electroshocks delay seizures and subsequent epileptogenesis but do not prevent neuronal damage in the lithium-pilocarpine model of epilepsy. Epilepsy Res. 42, 7-22.
4. Babb, T.L., 1991. Bilateral pathological damage in temporal lobe epilepsy. Can. J. Neurol. Sci. 18, 645-648.
5. Bialer, M., Johannessen, S.I., Levy, R.H., Perucca, E., Tomson, T., White, H.S., 2010. Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X). Epilepsy Res. 92, 89-124.
6. Carçak, N., Ferrandon, A., Koning, E., Aker, R.G., Ozdemir, O., Onat, F.Y., Nehlig, A., 2009. Effect of stage 2 kindling on local cerebral blood flow rates in rats with genetic absence epilepsy. Epilepsia 50, 33-43.
7. Cavalheiro, E.A.,1995. The pilocarpine model of epilepsy. Ital. J. Neurol. Sci.16, 33-37.
8. Cavdar, S., Onat, F.Y., Cakmak, Y.O., Yananli, H.R., Gülçebi, M., Aker, R., 2008. The pathways connecting the hippocampal formation, the thalamic reuniens nucleus and the thalamic reticular nucleus in the rat. J. Anat. 212, 249-256. (Pubitemid 351325481)
9. Chu, K., Jung, K.H., Lee, S.T., Kim, J.H., Kang, K.M., Kim, H.K., Lim, J.S., Park, H.K., Kim, M., Lee, S.K., Roh, J.K., 2008. Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 49, 1723-1732.
10. Cunha, A.O., Mortari, M.R., Liberato, J.L., dos Santos, W.F., 2009. Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus. Basic Clin. Pharmacol. Toxicol. 104, 470-477.
11. Danober, L., Deransart, C., Depaulis, A., Vergnes, M., Marescaux, C., 1998. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog. Neurobiol. 55, 27-57.
12. Deshpande, L.S., Nagarkatti, N., Ziobro, J.M., Sombati, S., DeLorenzo, R.J., 2008. Carisbamate prevents the development and expression of spontaneous recurrent epileptiform discharges and is neuroprotective in cultured hippocampal neurons. Epilepsia 49, 1795-1802.
13. Dube, C., Boyet, S., Marescaux, C., Nehlig, A., 2000. Progressive metabolic changes underlying the chronic reorganization of brain circuits during the silent phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat. Exp. Neurol. 162, 146-157.
14. Dube, C., da Silva Fernandes, M.J., Nehlig, A., 2001a. Age-dependent consequences of seizures and the development of temporal lobe epilepsy in the rat. Dev. Neurosci. 23, 219-223.
15. Dube, C., Boyet, S., Marescaux, C., Nehlig, A., 2001b. Relationship between neuronal loss and interictal glucose metabolism during the chronic phase of the lithiumpilocarpine model of epilepsy in the immature and adult rat. Exp. Neurol. 167, 227-241.
16. Engel Jr., J., 1996. Introduction to temporal lobe epilepsy. Epilepsy Res. 26, 141-150.
17. Faught, E., Holmes, G.L., Rosenfeld, W.E., Novak, G., Neto, W., Greenspan, A., Schmitt, J., Yuen, E., Reines, S., Haas, M., 2008. Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures. Neurology 71, 1586-1593.
18. Francois, J., Koning, E., Ferrandon, A., Nehlig, A., 2006. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res. 72, 147-163. (Pubitemid 44879899)
19. Francois, J., Boehrer, A., Nehlig, A., 2008. Effects of carisbamate (RWJ-333369) in two models of Genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS. Epilepsia 49, 393-399. (Pubitemid 351294523)
20. Grabenstatter, H.L., 2004. The use of chronic models in antiepileptic drug discovery: the effect of RWJ-333369 on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 45, 197 (Abstract).
21. Hanaya, R., Koning, E., Ferrandon, A., Nehlig, A., 2008. The role of the inherited genetic background on the consequences of lithium-pilocarpine status epilepticus: study in genetic absence epilepsy rats from Strasbourg and Wistar audiogenic rats. Neurobiol. Dis. 31, 451-458.
22. Jutila, L., Ylinen, A., Partanen, K., Alafuzoff, I., Mervaala, E., Partanen, J., Vapalahti, M., Vainio, P., Pitkanen, A., 2001. MR volumetry of the entorhinal, perirhinal, and temporopolar cortices in drug-refractory temporal lobe epilepsy. Am. J. Neuroradiol. 22, 1490-1501.
23. Klitgaard, H.V., Matagne, A.C., Vanneste-Goemaere, J., Margineanu, D.G., 2001. Effects of prolonged administration of levetiracetam on pilocarpine-induced epileptogenesis in rats. Epilepsia 42, 114-115 (Abstract).
24. Koutroumanidis, M., Hennessy, M.J., Elwes, R.D., Binnie, C.D., Polkey, C.E., 1999. Coexistence of temporal lobe and idiopathic generalized epilepsies. Neurology 53, 490-495. (Pubitemid 29382040)
25. Liu, Y., Yohrling, G.J., Wang, Y., Hutchinson, T.L., Brenneman, D.E., Flores, C.M., Zhao, B., 2009. Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons. Epilepsy Res. 83, 66-72.
26. Logroscino, G., Hesdorffer, D.C., Cascino, G.D., Annegers, J.F., Bagiella, E., Hauser, W.A., 2002. Long-term mortality after a first episode of status epilepticus. Neurology 58, 537-541. (Pubitemid 34164933)
27. Longo, B.M., Mello, L.E., 1997. Blockade of pilocarpine- or kainate-induced mossy fiber sprouting by cycloheximide does not prevent subsequent epileptogenesis in rats. Neurosci. Lett. 226, 163-166.
28. Longo, B.M., Mello, L.E., 1999. Effect of long-term spontaneous recurrent seizures or reinduction of status epilepticus on the development of supragranular mossy fiber sprouting. Epilepsy Res. 36, 233-241. (Pubitemid 29457583)
29. Loscher, W., Brandt, C., 2010. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol. Rev. 62, 668-700.
30. Mathern, G.W., Babb, T.L., Leite, J.P., Pretorius, K., Yeoman, K.M., Kuhlman, P.A., 1996. The pathogenic and progressive features of chronic human hippocampal epilepsy. Epilepsy Res. 26, 151-161. (Pubitemid 26420739)
31. Mello, L.E., Cavalheiro, E.A., Tan, A.M., Kupfer, W.R., Pretorius, J.K., Babb, T.L., Finch, D.M., 1993. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34, 985-995. (Pubitemid 24004233)
32. Natsume, J., Bernasconi, N., Andermann, F., Bernasconi, A., 2003. MRI volumetry of the thalamus in temporal, extratemporal, and idiopathic generalized epilepsy. Neurology 60, 1296-1300. (Pubitemid 36460985)
33. Nicolson, A., Chadwick, D.W., Smith, D.F., 2004. The coexistence of idiopathic generalized epilepsy and partial epilepsy. Epilepsia 45, 682-685. (Pubitemid 38802199)
34. Nissinen, J., Lukasiuk, K., Pitkänen, A., 2001. Is mossy fiber sprouting present at the time of the first spontaneous seizures in rat experimental temporal lobe epilepsy? Hippocampus 11, 299-310.
35. Novak, G.P., Kelley, M., Zannikos, P., Klein, B., 2007. Carisbamate (RWJ-333369). Neurotherapeutics 4, 106-109. (Pubitemid 46107332)
36. Pierce, J.P., Melton, J., Punsoni, M., McCloskey, D.P., Scharfman, H.E., 2005. Mossy fibers are the primary source of afferent input to ectopic granule cells that are born after pilocarpine-induced seizures. Exp. Neurol. 196, 316-331.
37. Pitkanen, A., Kubova, H., 2004. Antiepileptic drugs in neuroprotection. Expert Opin. Pharmacother. 5, 777-798.
38. Pitkanen, A., Kharatishvili, I., Narkilahti, S., Lukasiuk, K., Nissinen, J., 2005. Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat. Epilepsy Res. 63, 27-42. (Pubitemid 40215778)
39. Pitkänen, A., 2010. Therapeutic approaches to epileptogenesisehope on the horizon. Epilepsia 51 (Suppl. 3), 2-17.
40. Pitkänen, A., Tuunanen, J., Kälviäinen, R., Partanen, K., Salmenperä, T., 1998. Amygdala damage in experimental and human temporal lobe epilepsy. Epilepsy Res. 32, 233-253. (Pubitemid 28419493)
41. Prasad, A., Williamson, J.M., Bertram, E.H., 2002. Phenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus. Ann. Neurol. 51, 175-181.
42. Represa, A., Le Gall La Salle, G., Ben-Ari, Y., 1989. Hippocampal plasticity in the kindling model of epilepsy in rats. Neurosci. Lett. 99, 345-350.
43. Rigau, V., Morin, M., Rousset, M.C., de Bock, F., Lebrun, A., Coubes, P., Picot, M.C., Baldy-Moulinier, M., Bockaert, J., Crespel, A., Lerner-Natoli, M., 2007. Angiogenesis is associated with bloodebrain barrier permeability in temporal lobe epilepsy. Brain 130, 1942-1956. (Pubitemid 47343810)
44. Rigoulot, M.A., Leroy, C., Koning, E., Ferrandon, A., Nehlig, A., 2003. Prolonged low-dose caffeine exposure protects against hippocampal damage but not against the occurrence of epilepsy in the lithium-pilocarpinemodel in the rat. Epilepsia 44, 529-535.
45. Rigoulot, M.A., Koning, E., Ferrandon, A., Nehlig, A., 2004. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy. J. Pharmacol. Exp. Ther. 308, 787-795.
46. Roch, C., Leroy, C., Nehlig, A., Namer, I.J., 2002a. Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia 43, 325-335. (Pubitemid 34297169)
47. Roch, C., Leroy, C., Nehlig, A., Namer, I.J., 2002b. Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine model. Epilepsia 43, 1129-1136. (Pubitemid 35176117)
48. Santhakumar, V., Aradi, I., Soltesz, I., 2005. Role of mossy fiber sprouting and mossy cell loss in hyperexcitability: a network model of the dentate gyrus incorporating cell types and axonal topography. J. Neurophysiol. 93, 437-453. (Pubitemid 40626852)
49. Scharfman, H.E., Sollas, A.L., Berger, R.E., Goodman, J.H., 2003. Electrophysiological evidence of monosynaptic excitatory transmission between granule cells after seizure-induced mossy fiber sprouting. J. Neurophysiol. 90, 2536-2547. (Pubitemid 37266522)
50. Sperling, M.R., Greenspan, A., Cramer, J.A., Kwan, P., Kalviainen, R., Halford, J.J., Schmitt, J., Yuen, E., Cook, T., Haas, M., Novak, G., 2010. Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials. Epilepsia 51, 333-343.
51. Stepień, K., Tomaszewski, M., Czuczwar, S.J., 2005. Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugsean update. Pharmacol. Rep. 57, 719-733.
52. Sutula, T., 2002. Seizure-Induced axonal sprouting: assessing connections between injury, local circuits, and epileptogenesis. Epilepsy Curr. 2, 86-91.
53. Sutula, T., Cascino, G., Cavazos, J., Parada, I., Ramirez, L., 1989. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol. 26, 321-330.
54. Whalley, B.J., Stephens, G.J., Constanti, A., 2009. Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro. Br. J. Pharmacol. 156, 994-1008.
55. White, H.S., Klein, B., Zhao, B., Choi, Y.M., Gordon, R., 2006. The novel investigational neuromodulator RWJ 333369 displays a broad-spectrum anticonvulsant profile in rodent seizure and epilepsy models (abstract). Epilepsia 47.
56. Zhang, D.X., Bertram, E.H., 2002. Midline thalamic region: widespread excitatory input to the entorhinal cortex and amygdala. J. Neurosci. 22, 3277-3284. (Pubitemid 35379215)
57. Zhou, J.L., Zhao, Q., Holmes, G.L., 2007. Effect of levetiracetam on visual-spatial memory following status epilepticus. Epilepsy Res. 73, 65-74. (Pubitemid 46073606)